CINCINNATI (May 24, 2012) — Omnicare, Inc. (NYSE:OCR) today announced the appointment of Sam R. Leno to its board of directors and he will also become a member of the audit committee.
The board also approved a quarterly cash dividend of $0.07 per share on its common stock. The dividend is payable on June 22 to stockholders of record on June 8.
Leno has more than 40 years of business experience with multinational companies, the vast majority within the healthcare sector. He recently retired as executive vice president and chief operations officer at Boston Scientific, where he was responsible for the finance, information systems, operations, business development, strategy and restructuring functions.